|Articles|February 3, 2022

CTMA Expands to Rheumatology

Recruiting software for HCPs now available in three rheumatological areas.

CTMA has announced that it is expanding its CT-SCOUT™ technology offering into a second therapeutic area–rheumatology. CT-SCOUT™, the company’s multi-device platform that allows health care professionals (HCP) to identify trial candidates, will now be available for sites, sponsors and contract research organizations (CROs) in three rheumatological indications: Rheumatoid Arthritis, Ankylosing Spondylarthritis and Psoriatic Rheumatism.

Read more about the announcement here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content